Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 26, 2022

BUY
$59.54 - $68.01 $144,979 - $165,604
2,435 Added 12.69%
21,629 $1.33 Million
Q2 2022

Jul 12, 2022

BUY
$57.72 - $65.01 $52,352 - $58,964
907 Added 4.96%
19,194 $1.19 Million
Q1 2022

Apr 19, 2022

BUY
$57.92 - $72.58 $63,654 - $79,765
1,099 Added 6.39%
18,287 $1.09 Million
Q4 2021

Jan 24, 2022

BUY
$64.88 - $73.64 $86,030 - $97,646
1,326 Added 8.36%
17,188 $1.25 Million
Q3 2021

Oct 13, 2021

BUY
$67.69 - $73.03 $19,427 - $20,959
287 Added 1.84%
15,862 $1.11 Million
Q2 2021

Oct 13, 2021

BUY
$63.47 - $69.35 $12,694 - $13,869
200 Added 1.3%
15,575 $1.07 Million
Q1 2021

Oct 13, 2021

SELL
$60.0 - $68.46 $1.43 Million - $1.64 Million
-23,916 Reduced 60.87%
15,375 $994,000
Q4 2020

Oct 13, 2021

BUY
$56.65 - $64.55 $11,556 - $13,168
204 Added 0.52%
39,291 $2.29 Million
Q3 2020

Oct 13, 2021

BUY
$62.1 - $78.08 $36,204 - $45,520
583 Added 1.51%
39,087 $2.47 Million
Q2 2020

Oct 13, 2021

SELL
$72.34 - $84.0 $1.27 Million - $1.47 Million
-17,533 Reduced 31.29%
38,504 $2.96 Million
Q1 2020

Oct 13, 2021

BUY
$62.63 - $80.22 $2.74 Million - $3.5 Million
43,688 Added 353.78%
56,037 $4.19 Million
Q4 2019

Oct 13, 2021

BUY
$61.62 - $67.78 $760,945 - $837,015
12,349 New
12,349 $802,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Hixon Zuercher, LLC Portfolio

Follow Hixon Zuercher, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hixon Zuercher, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hixon Zuercher, LLC with notifications on news.